Skip to content

Author

H. Yasui

We have 2 of 264 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Efficacy and Safety of Reduced-Dose Chemotherapy Plus Nivolumab in Elderly Advanced Gastric Cancer

Reduced-dose chemotherapy plus nivolumab may be an effective and less toxic first-line option for elderly patients with AGC, according to retrospectively collected clinical data from 70 patients aged 70 years or older with AGC.

Toshihiko Matsumoto, S. Sugimoto, R. Omori et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.